< 0 1 0 1 O
5 2 3 2 3 B-upper_bound
pack 4 8 4 8 I-upper_bound
year 9 13 9 13 I-upper_bound
( 14 15 14 15 I-upper_bound
p 15 16 15 16 I-upper_bound
- 16 17 16 17 I-upper_bound
y 17 18 17 18 I-upper_bound
) 18 19 18 19 I-upper_bound
history 20 27 20 27 O
of 28 30 28 30 O
tobacco 31 38 31 38 O
use 39 42 39 42 O

> 0 1 43 44 O
18 2 4 45 47 B-lower_bound
years 5 10 48 53 I-lower_bound
of 11 13 54 56 O
age 14 17 57 60 B-age

Allergic 0 8 61 69 B-chronic_disease
Asthma 9 15 70 76 I-chronic_disease
Population 16 26 77 87 I-chronic_disease
( 27 28 88 89 I-chronic_disease
AA 28 30 89 91 I-chronic_disease
) 30 31 91 92 I-chronic_disease

Cardiac 0 7 93 100 B-chronic_disease
Disease 8 15 101 108 I-chronic_disease

FEV1 0 4 109 113 B-clinical_variable
< 5 6 114 115 O
60 6 8 115 117 B-upper_bound
% 8 9 117 118 I-upper_bound
predicted 10 19 119 128 O
normal 20 26 129 135 O
pre 27 30 136 139 B-treatment
- 30 31 139 140 I-treatment
bronchodilator 31 45 140 154 I-treatment

Has 0 3 155 158 O
asthma 4 10 159 165 B-chronic_disease
according 11 20 166 175 O
to 21 23 176 178 O
Phase 24 29 179 184 O
I 30 31 185 186 O
diagnostic 32 42 187 197 O
criteria 43 51 198 206 O

Inhaled 0 7 207 214 B-treatment
corticosteroid 8 22 215 229 I-treatment
use 23 26 230 233 O
in 27 29 234 236 O
previous 30 38 237 245 B-lower_bound
1 39 40 246 247 I-lower_bound
month 41 46 248 253 I-lower_bound
or 47 49 254 256 O
more 50 54 257 261 O
will 55 59 262 266 O
be 60 62 267 269 O
allowed 63 70 270 277 O

Oral 0 4 278 282 B-treatment
corticosteroid 5 19 283 297 I-treatment
treatment 20 29 298 307 I-treatment
within 30 36 308 314 O
the 37 40 315 318 O
last 41 45 319 323 B-upper_bound
4 46 47 324 325 I-upper_bound
weeks 48 53 326 331 I-upper_bound

Patients 0 8 332 340 O
will 9 13 341 345 O
be 14 16 346 348 O
recruited 17 26 349 358 O
from 27 31 359 363 O
the 32 35 364 367 O
NYUBAR 36 42 368 374 O
and 43 46 375 378 O
will 47 51 379 383 O
have 52 56 384 388 O
no 57 59 389 391 O
respiratory 60 71 392 403 O
symptoms 72 80 404 412 O
, 80 81 412 413 O
no 82 84 414 416 O
asthma 85 91 417 423 B-chronic_disease
diagnosis 92 101 424 433 O
, 101 102 433 434 O
no 103 105 435 437 O
WTC 106 109 438 441 O
dust 110 114 442 446 O
exposure 115 123 447 455 O
, 123 124 455 456 O
no 125 127 457 459 O
current 128 135 460 467 O
tobacco 136 143 468 475 O
use 144 147 476 479 O
, 147 148 479 480 O
≤ 149 150 481 482 O
5 151 152 483 484 B-upper_bound
p 153 154 485 486 I-upper_bound
- 154 155 486 487 I-upper_bound
y 155 156 487 488 I-upper_bound
history 157 164 489 496 O
of 165 167 497 499 O
tobacco 168 175 500 507 O
use 176 179 508 511 O
, 179 180 511 512 O
and 181 184 513 516 O
normal 185 191 517 523 O
spirometry 192 202 524 534 O
with 203 207 535 539 O
no 208 210 540 542 O
bronchodilator 211 225 543 557 O
response 226 234 558 566 O
and 235 238 567 570 O
negative 239 247 571 579 O
methacholine 248 260 580 592 O
challenge 261 270 593 602 O
in 271 273 603 605 O
past 274 278 606 610 B-upper_bound
6 279 280 611 612 I-upper_bound
months 281 287 613 619 I-upper_bound

Patients 0 8 620 628 O
will 9 13 629 633 O
be 14 16 634 636 O
recruited 17 26 637 646 O
from 27 31 647 651 O
the 32 35 652 655 O
NYUBAR 36 42 656 662 O
or 43 45 663 665 O
advertisement 46 59 666 679 O
and 60 63 680 683 O
will 64 68 684 688 O
have 69 73 689 693 O
asthma 74 80 694 700 B-chronic_disease
as 81 83 701 703 O
defined 84 91 704 711 O
by 92 94 712 714 O
NIH 95 98 715 718 O
guidelines 99 109 719 729 O
, 109 110 729 730 O
persistent 111 121 731 741 O
symptoms 122 130 742 750 O
, 130 131 750 751 O
absence 132 139 752 759 O
of 140 142 760 762 O
WTC 143 146 763 766 O
dust 147 151 767 771 O
exposure 152 160 772 780 O

Pulmonary 0 9 781 790 B-chronic_disease
diseases 10 18 791 799 I-chronic_disease
such 19 23 800 804 O
as 24 26 805 807 O
Chronic 27 34 808 815 B-chronic_disease
Pulmonary 35 44 816 825 I-chronic_disease
Disease 45 52 826 833 I-chronic_disease
( 53 54 834 835 I-chronic_disease
COPD 54 58 835 839 I-chronic_disease
) 58 59 839 840 I-chronic_disease
or 60 62 841 843 O
Interstitial 63 75 844 856 B-chronic_disease
Lung 76 80 857 861 I-chronic_disease
Disease 81 88 862 869 I-chronic_disease

Spirometry 0 10 870 880 B-treatment
in 11 13 881 883 O
the 14 17 884 887 O
past 18 22 888 892 B-lower_bound
6 23 24 893 894 I-lower_bound
months 25 31 895 901 I-lower_bound
or 32 34 902 904 O
on 35 37 905 907 O
day 38 41 908 911 O
of 42 44 912 914 O
evaluation 45 55 915 925 O
with 56 60 926 930 O
a 61 62 931 932 O
bronchodilator 63 77 933 947 B-clinical_variable
* 77 78 947 948 I-clinical_variable
response 79 87 949 957 I-clinical_variable
of 88 90 958 960 O
≥ 91 92 961 962 O
12 93 95 963 965 B-lower_bound
% 95 96 965 966 I-lower_bound
and 97 100 967 970 O
200 101 104 971 974 B-lower_bound
ml 105 107 975 977 I-lower_bound
improvement 108 119 978 989 O
in 120 122 990 992 O
FEV 123 126 993 996 B-clinical_variable

Symptoms 0 8 997 1005 O
of 9 11 1006 1008 O
wheeze 12 18 1009 1015 B-clinical_variable
and 19 22 1016 1019 I-clinical_variable
shortness 23 32 1020 1029 I-clinical_variable
of 33 35 1030 1032 I-clinical_variable
breath 36 42 1033 1039 I-clinical_variable
( 43 44 1040 1041 O
> 44 45 1041 1042 O
2x 46 48 1043 1045 B-lower_bound
/ 49 50 1046 1047 I-lower_bound
week 51 55 1048 1052 I-lower_bound
) 55 56 1052 1053 O
in 57 59 1054 1056 O
the 60 63 1057 1060 O
4 64 65 1061 1062 B-upper_bound
weeks 66 71 1063 1068 I-upper_bound
before 72 78 1069 1075 O
inclusion 79 88 1076 1085 O
( 89 90 1086 1087 O
persistent 90 100 1087 1097 O
symptoms 101 109 1098 1106 O
) 109 110 1106 1107 O

Upper 0 5 1108 1113 B-chronic_disease
respiratory 6 17 1114 1125 I-chronic_disease
tract 18 23 1126 1131 I-chronic_disease
infection 24 33 1132 1141 I-chronic_disease
within 34 40 1142 1148 O
the 41 44 1149 1152 O
last 45 49 1153 1157 B-upper_bound
4 50 51 1158 1159 I-upper_bound
weeks 52 57 1160 1165 I-upper_bound

≥ 0 1 1166 1167 O
20 2 4 1168 1170 B-lower_bound
% 4 5 1170 1171 I-lower_bound
( 6 7 1172 1173 O
PC20 7 11 1173 1177 O
) 11 12 1177 1178 O
after 13 18 1179 1184 O
inhalation 19 29 1185 1195 O
of 30 32 1196 1198 O
< 33 34 1199 1200 O
16 35 37 1201 1203 B-upper_bound
mg 38 40 1204 1206 I-upper_bound
/ 40 41 1206 1207 I-upper_bound
ml 41 43 1207 1209 I-upper_bound
of 44 46 1210 1212 O
methacholine 47 59 1213 1225 B-treatment
) 59 60 1225 1226 O

